PROF

Profound Medical Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth 0/10
  • Value 0/10
Profound Medical sales and earnings growth
PROF Growth
Low
  • Revenue Y/Y 50.73%
  • EPS Y/Y -25.89%
  • FCF Y/Y -63.66%
Profound Medical gross and profit margin trends
PROF Profitability
Neutral
  • Gross margin 70.80%
  • EPS margin -264.40%
  • ROIC 5Y -199.26%
Profound Medical net debt vs free cash flow
PROF Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -40.5

Profound Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗